But when you combine glucagon receptor agonism with strong GLP-1 and GIP activity, something interesting happens: GLP-1 and GIP's insulin-stimulating effects offset glucagon's glucose-raising tendency, and what's left is glucagon's other effects increased hepatic energy expenditure, upregulated fatty-acid oxidation, and thermogenesis
Accessing Expert Care Through Telehealth As the landscape of diabetes and obesity treatment evolves, access to knowledgeable healthcare providers is essential
No, BPC-157 is not a steroid
The study suggests that BPC 157 may counteract excessive activation or mitigation within these signaling networks
Confirmatory secondary endpoints included relative change in bodyweight (%) from baseline to week 40
Alternatives the physician considered, including the option of no treatment